Clinical trial
A Study of the Transition From Cangrelor to Clopidogrel or Prasugrel in Patients With Coronary Artery Disease.
NCT01979445 is registered in ClinicalTrials.gov with The Medicines Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study of the Transition From Cangrelor to Clopidogrel or Prasugrel in Patients With Coronary Artery Disease.
- Lead sponsor
- The Medicines Company
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 2, 2013
- Completion date
- January 20, 2014
- Enrollment
- 15 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
coronary artery disease (cad)